HSPC159 Promotes Proliferation and Metastasis via Inducing EMT and Activating PI3K/Akt Pathway in Breast Cancer

Cancer Science - United States
doi 10.1111/cas.13631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

TrkB Promotes Laryngeal Cancer Metastasis via Activation PI3K/AKT Pathway

Oncotarget
Oncology
2017English

NRSN2 Promotes Breast Cancer Metastasis by Activating PI3K/AKT/mTOR and NF‑κB Signaling Pathways

Oncology Letters
Cancer ResearchOncology
2019English

ZNF692 Promotes Colon Adenocarcinoma Cell Growth and Metastasis by Activating the PI3K/AKT Pathway

International Journal of Oncology
Cancer ResearchOncology
2019English

Up-Regulation of IGF2BP2 by Multiple Mechanisms in Pancreatic Cancer Promotes Cancer Proliferation by Activating the PI3K/Akt Signaling Pathway

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Upregulation of HES1 Promotes Cell Proliferation and Invasion in Breast Cancer as a Prognosis Marker and Therapy Target via the AKT Pathway and EMT Process

Journal of Cancer
Oncology
2018English

NECTIN4 Promotes Papillary Thyroid Cancer Cell Proliferation, Migration, and Invasion and Triggers EMT by Activating AKT [Corrigendum]

Cancer Management and Research
Oncology
2019English

LncRNA SNHG6 Inhibits Cell Proliferation and Metastasis by Targeting ETS1 via the PI3K/AKT/mTOR Pathway in Colorectal Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

TROAP Promotes Breast Cancer Proliferation and Metastasis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

RUNX1 Promotes Tumour Metastasis by Activating the WNT/Β-Catenin Signalling Pathway and EMT in Colorectal Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy